Central Retinal Vein Occlusion: eMedicine Ophthalmology
Links shared publicly online about this topic.
- 828total visits
Central Retinal Vein Occlusion: eMedicine Ophthalmology
View full resource at emedicine.medscape.com
Tags: Circulation, Edema, Disease and Condition, Optics, Ophthalmology
Most Recently Shared on October 3, 2010 at 5:28 pm By:
Intraocular injections of 0.3mg/0.5mg ranibizumab showed improvement in 6mo. visual acuity & macular edema in CRVO: http://bit.ly/bGm7Tu
Current Insight : American Academy of Ophthalmology
one.aao.org — “Current Insight : American Academy of Ophthalmology” View full resource at one.aao.org
Most Recently Shared on November 6, 2011 at 2:38 pm By:
Rob Melendez, MD, MBA Physician, Active Health Library, Doctor, Surgeon, and Ophthalmologist
Current Insight : American Academy of Ophthalmology http://t.co/yjSz3AlM
aspirin contraindicated in retinal vein occlusion
eyedocnews.com — “aspirin and plavix made the vision worse in central retinal vein occlusions” View full resource at eyedocnews.com
Most Recently Shared on August 30, 2011 at 10:05 am By:
Dr. Ari Weitzner Physician, Doctor, and Ophthalmologist
Discuss: Aspirin Contraindicated in Central Retinal Vein Occlusion: Ophthalmology: Here’s an interesting, counte... http://t.co/Qe6W2fI
Ozurdex recommended for treating macular oedema - Ophthalmology Times Europe
oteurope.com — “The National Institute for Health and Clinical Excellence (NICE) has recommended Ozurdex for the treatment of macular oedema caused by central retinal vein occlusion (CRVO).” View full resource at oteurope.com
Most Recently Shared on June 16, 2011 at 12:34 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
News Update: Ozurdex recommended for treating macular oedema http://ow.ly/1dgQww
Ranibizumab can be used for long-term CRVO - Ophthalmology Times Europe
oteurope.com — “Visual acuity and central retinal thickness in patients with central retinal vein occlusion (CRVO) have been improved with intravitreal ranibizumab treatment, according to a study published in Retina.” View full resource at oteurope.com
Most Recently Shared on May 10, 2011 at 12:34 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
News Update: Ranibizumab can be used for long-term CRVO - Visual acuity and central retinal thickness in patients wi... http://ow.ly/1cAkek
Anti-VEGF yields favorable outcomes for treatment-nave retinal vein occlusion
osnsupersite.com — “Intravitreal ranibizumab improved visual acuity and reduced central macular thickness in eyes with treatment-naïve retinal vein occlusion,” View full resource at osnsupersite.com
Most Recently Shared on February 7, 2011 at 4:09 pm By:
Anti-VEGF yields favorable outcomes for treatment-naïve retinal vein occlusion: http://ht.ly/3RHY3 — #ophthalmology #news
FDA approves anti-VEGF for treatment of branch, central retinal vein occlusion
osnsupersite.com — “SOUTH SAN FRANCISCO, Calif. " Following a 6-month priority review, the U.S. Food and Drug Administration has approved ranibizumab for treatment” View full resource at osnsupersite.com
Most Recently Shared on June 23, 2010 at 2:22 pm By:
#FDA approves anti-VEGF for treatment of branch, central retinal vein occlusion: http://ht.ly/22dYb — #Breaking #ophthalmology #news
Medical News: Steroids Effective for Some Retinal Vein Occlusions - in Ophthalmology, Ophthalmology from MedPage Today
medpagetoday.com — “A steroid injection may improve vision in patients with a central retinal vein occlusion, researchers found.” View full resource at medpagetoday.com
Most Recently Shared on September 16, 2009 at 5:52 pm By:
Steroids Effective for Some Retinal Vein Occlusions (CME/CE) http://ow.ly/15PjYf
Ophthalmology News - OphthalmologyWeb - The 'Eyesite' for Ophthalmologists
ophthalmologyweb.com — “Ophthalmology News - OphthalmologyWeb - The 'Eyesite' for Ophthalmologists” View full resource at ophthalmologyweb.com
Most Recently Shared on September 15, 2009 at 6:43 pm By:
News: New Treatment Found To Reduce Vision Loss From Central Retinal Vein Occlusion http://ow.ly/15P9qt
Drug therapy for macular oedema treatment approved - Ophthalmology Times Europe
oteurope.com — “Ozurdex, the first drug therapy for the treatment of macular oedema, following branch retinal vein occlusion or central retinal vein occlusion, has been approved by the FDA.” View full resource at oteurope.com
Most Recently Shared on June 25, 2009 at 1:32 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
Drug therapy for macular oedema treatment approved. http://ow.ly/fOO4
Intravitreous Injections of Pegaptanib (Macugen) May Help Prevent Further Vision Loss From Central Retinal Vein Occlusion
eyedocnews.com — “As recently reported in MedPage Today, a study published in the April 2009 issue of The Archives of Ophthalmology, researchers have found that intravitreous” View full resource at eyedocnews.com
Most Recently Shared on May 3, 2009 at 4:47 am By:
Dr. Ari Weitzner Physician, Doctor, and Ophthalmologist
Discuss: Intravitreous Injections of Pegaptanib (Macugen) May Help Prevent Further Vision Loss From Cent.. http://tinyurl.com/dj5bta
Medical News: Intravitreous Pegaptanib Could Halt Vision Loss - in Ophthalmology, Ophthalmology from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Intravitreous injection of pegaptanib (Macugen) may help prevent further vision loss from central retinal vein occlusion but does little to reverse it, researchers found.” View full resource at medpagetoday.com
Most Recently Shared on April 17, 2009 at 8:42 pm By:
Intravitreous Pegaptanib Could Halt CRVO Vision Loss http://medpagetoday.com/13802
Advertisement
